跳至主要内容
临床试验/NL-OMON19911
NL-OMON19911招募中不适用

Anticoagulation in patients with brain cancer: an international registry

Amsterdam UMC - location AMC0 个研究点目标入组 2,200 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,200

研究概览

简要总结

eader A, Hamulyák EN, Carney BJ, et al. Intracranial Hemorrhage with Direct Oral Anticoagulants in Patients with Brain Metastases [abstract]. Res Pr Thromb Haemost. 2020;4(Suppl 1). https://abstracts.isth.org/abstract/intracranial-hemorrhage-with-direct-oral-anticoagulants-in-patients-with-brain-metastases/. Accessed September 9, 2020.

研究设计

研究类型
Observational

入排标准

入选标准

  • 1) Active high-grade glioma or confirmed presence of brain metastases
  • 2) DOAC or LMWH prescribed at therapeutic doses in the presence of active brain cancer, for any indication and any duration
  • 3) At least two neuroimaging studies (computed tomography (CT) or magnetic resonance imaging (MRI)) from index day until the end of 12-month follow-up, unless death occurs first.

排除标准

  • 1) Intracranial hemorrhage before initiation of anticoagulation
  • 2) Lack of follow-up data

研究者

发起方
Amsterdam UMC - location AMC

相似试验